THE ASAHI SHIMBUN
January 21, 2021 at 12:51 JST
Japan will receive 144 million doses of the COVID-19 vaccine manufactured by U.S. drugmaker Pfizer Inc. (Provided by Pfizer Inc.)
Japan has signed a contract with U.S. pharmaceutical company Pfizer Inc. for about 144 million doses of its COVID-19 vaccine this year, enough to inoculate 72 million people, health minister Norihisa Tamura said Jan. 20.
The Japanese government plans to start administering the vaccine, co-manufactured with German biocommerce company BioNTech, on medical workers by late February.
The ministry struck a basic agreement with Pfizer in July 2020 for enough doses to inoculate 60 million people by the end of June. The formal contract extends that period and provides Japan with more doses.
Tamura told reporters the government hopes Pfizer will provide “as many (doses) as possible by the end of the first half of this year.”
The Japanese government also signed formal contracts with two other companies--Moderna Inc. in October and AstraZeneca in December--for their COVID-19 vaccines.
High hurdles await Japan’s unprecedented vaccine program
January 20, 2021
In virus surge, more hospitals turning away ambulances
January 20, 2021
COVID-19 cases in Tokyo hover above 1,000 for 8th straight day
January 20, 2021
Okinawa issues 3rd state of emergency over spread of virus
January 20, 2021
Japan reports 1st likely community transmission of virus variant
January 19, 2021
Visit this page for the latest news on Japan’s battle with the novel coronavirus pandemic.
A mother of two sons recounts the days when she lived with the novel coronavirus.
Historians describe the Nomonhan Incident, a little-known 1939 Japan-Soviet border conflict, as the starting point of World War II.
The Asahi Shimbun aims “to achieve gender equality and empower all women and girls” through its Gender Equality Declaration.
Let’s explore the Japanese capital from the viewpoint of wheelchair users and people with disabilities with Barry Joshua Grisdale.
